---
date created: 2024-11-16
tags:
  - meds
---
**Class:**
- Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)

**Mechanism of Action (MOA):**
- Enhances central noradrenergic and serotonergic activity by antagonizing central presynaptic alpha-2 adrenergic receptors.

**Indications/Uses:**
- Major Depressive Disorder (MDD)

**Side Effects:**
- Drowsiness
- Increased appetite
- Weight gain
- Dry mouth
- Dizziness

**Adverse Effects:**
- Agranulocytosis (rare)
- Suicidal thoughts
- Increased cholesterol levels

**Nursing Teaching and Implications:**
- Educate about potential sedative effects.
- Advise on monitoring weight and dietary intake.
- Discuss the importance of not abruptly discontinuing the medication.

**Contraindications:**
- Concurrent use with MAO inhibitors
- Known hypersensitivity to mirtazapine